|Articles|August 30, 2016
CMIC HOLDINGS Implements goBalto Activate
Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia.
Advertisement
Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia. The CRO looks for the solution to improve workflows of studies being conducted in Malaysia, Singapore, Taiwan, Philippines, Thailand, Japan and South Korea.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What It Actually Means to Embed the Patient Voice in Trial Design
2
Recruitment in the Age of AI: Q&A with John Worden, Javara
3
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
4
ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization
5